Lipo C

Lipo C (also called LIP-C or Lip C) is a compounded injectable formulation. It typically combines methionine, inositol, choline (MIC), plus B vitamins like B12 and L-carnitine. These lipotropic agents theoretically support fat utilization and methylation. However, clinical evidence for meaningful weight loss remains limited.

How Lipo C Works Theoretically
The proposed mechanism relies on enhancing fatty acid oxidation. Methionine provides methyl groups for detoxification pathways. Choline aids phospholipid synthesis and lipid transport. Inositol supports insulin signaling. Additionally, B vitamins help energy conversion. However, when your body already has adequate nutrient levels, extra supplementation produces minimal measurable benefit.

Clinical Evidence and Limitations
Peer-reviewed trials specifically testing Lipo C for weight loss are sparse. Most evidence comes from small observational studies or anecdotal reports. Consequently, the FDA has not approved Lipo C as a standalone weight-loss therapy. Patients relying on Lipo C alone typically experience slower results than those using evidence-based GLP-1 medications like semaglutide or tirzepatide. Those medications produce 15–24% weight loss in rigorous trials.

Stacking with GLP-1 Medications
Some clinics market Lipo C as an adjunct to GLP-1 therapy. The theoretical synergy is that semaglutide reduces appetite while Lipo C supports fat mobilization. However, no published randomized controlled trials examine this specific combination. Therefore, providers generally recommend optimizing your GLP-1 dose first before considering unproven adjuncts.

Genetic and Biomarker Context
Response may depend on baseline nutrient status and genetic variants. Genes like MTHFR, PEMT, and CHDH influence methylation and choline metabolism. Similarly, FTO and MC4R variants relate to energy expenditure. Testing can help guide informed decisions with your provider. For more on peptide and metabolic support, review our Metabolic Health Guide. Externally, consult the PubMed research repository for peer-reviewed literature.

Safety Considerations
Lipo C injections are generally well-tolerated. Common side effects include injection site irritation, nausea, and occasionally a fishy odor from choline. Patients with liver disease or trimethylaminuria should avoid choline supplementation. Always discuss with a healthcare practitioner before starting.